Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SY-009 in Patients With Type 2 Diabetes
NCT05426018Phase 2Unknown
- Sponsor
- Yabao Pharmaceutical Group Co., Ltd.
- Start
- Jul 2022
- Primary completion
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of yagratide in type 2 diabetes mellitus (T2DM), sponsored by Yabao Pharmaceutical Group Co., Ltd.. Status: unknown.
02
Drugs
yagratide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT05426018.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05426018.